Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2988
Title: Factors associated with Mycobacterium abscessus group (MABS) infection type in people with cystic fibrosis
Authors: Bell, S.
Wood, M.
Carter, R.
Tolson, C.
Pandey, S.
Coulter, C.
Thomson, R.
Wainwright, C. 
Stockwell, R.
Issue Date: 2019
Source: 18 , 2019, p. S102-S103
Pages: S102-S103
Journal: Journal of Cystic Fibrosis
Abstract: Objectives: Mycobacterium abscessus group (MABS) lung infection is associated with poorer health outcomes. However, some people with CF are able to clear MABS from the lungs spontaneously. We aimed to investigate factors which may influence whether an infection persists or clears spontaneously. Methods: Clinical and microbiological data were collected and analysed for 72 patients with CF and MABS infection (all cases from 2 CF centres, 2000–2017). The infection types were categorised as follows: “acute”, single or multiple MABS isolates detected ≤12 months; “chronic”, multiple isolates of similar/identical strain or subspecies (subsp.) >12 months; “reinfection”, multiple strains/subsp. detected >12 months; “co-infection”, multiple strains/subsp. detected ≤12 months. Results: 39/72 patients had acute infection, 20 had chronic infection, 5 had re-infections, 2 had co-infections and 6 were not classified (missing data). Clinical factors were similar between patients with acute and chronic infection (Table 1). Furthermore, microbiological factors were similar between acute and chronic infections: smear positivity (p = 0.16), MABS subspecies (p = 0.47), clonal M. a. abscessus infections (p = 0.19), Pseudomonas aeruginosa infection (p = 0.39), Aspergillus infection (p = 0.41) and other nontuberculousmycobacteria infection (p = 0.11). Of the 20 participants with a chronic infection, 14 were treated with antibiotics and 6 (43%) cleared the infection post-treatment. [Table Presented] Conclusions: Acute and chronic infections have similar characteristics. In those with chronic infections, the clearance of MABS is poor despite treatment. Grant Support: Cystic Fibrosis Foundation Therapeutics (USA), The Prince Charles Hospital Foundation, Advance Queensland.L20019766962019-11-07
DOI: 10.1016/S1569-1993(19)30453-9
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L2001976696&from=exporthttp://dx.doi.org/10.1016/S1569-1993(19)30453-9 |
Keywords: female;human;lung infection;major clinical study;male;coinfection;multicenter study;Mycobacterium abscessus;antibiotic agentadult;Pseudomonas infection;Queensland;reinfection;subspecies;nonhuman;aspergillosis;conference abstract;controlled study;cystic fibrosis;drug therapy
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

62
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.